FCGR3A and COVID-19: Along with an increase in the expression levels of HLA-DR and PD-1, and elevated IL-6 serum concentration, an increase in the CD16+ cell proportion among CD56− T cells may be considered the factor associated with increased COVID-19-mediated mortality.